146 related articles for article (PubMed ID: 35743138)
21. Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate.
Yaroslavskiy BB; Turkova I; Wang Y; Robinson LJ; Blair HC
Lab Invest; 2010 Oct; 90(10):1533-42. PubMed ID: 20567233
[TBL] [Abstract][Full Text] [Related]
22. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.
Geiger J; Nolte C; Butt E; Sage SO; Walter U
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):1031-5. PubMed ID: 1310537
[TBL] [Abstract][Full Text] [Related]
23. cGMP and cGMP-dependent protein kinase in platelets and blood cells.
Walter U; Gambaryan S
Handb Exp Pharmacol; 2009; (191):533-48. PubMed ID: 19089344
[TBL] [Abstract][Full Text] [Related]
24. Synergistic phosphorylation of the focal adhesion-associated vasodilator-stimulated phosphoprotein in intact human platelets in response to cGMP- and cAMP-elevating platelet inhibitors.
Nolte C; Eigenthaler M; Horstrup K; Hönig-Liedl P; Walter U
Biochem Pharmacol; 1994 Oct; 48(8):1569-75. PubMed ID: 7980622
[TBL] [Abstract][Full Text] [Related]
25. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
[TBL] [Abstract][Full Text] [Related]
26. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases.
Waldmann R; Nieberding M; Walter U
Eur J Biochem; 1987 Sep; 167(3):441-8. PubMed ID: 2820726
[TBL] [Abstract][Full Text] [Related]
27. Defective nitrovasodilator-stimulated protein phosphorylation and calcium regulation in cGMP-dependent protein kinase-deficient human platelets of chronic myelocytic leukemia.
Eigenthaler M; Ullrich H; Geiger J; Horstrup K; Hönig-Liedl P; Wiebecke D; Walter U
J Biol Chem; 1993 Jun; 268(18):13526-31. PubMed ID: 8390466
[TBL] [Abstract][Full Text] [Related]
28. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.
Nygaard G; Herfindal L; Kopperud R; Aragay AM; Holmsen H; Døskeland SO; Kleppe R; Selheim F
Biochem Biophys Res Commun; 2014 Jul; 449(3):357-63. PubMed ID: 24845383
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.
Zhang G; Han J; Welch EJ; Ye RD; Voyno-Yasenetskaya TA; Malik AB; Du X; Li Z
J Immunol; 2009 Jun; 182(12):7997-8004. PubMed ID: 19494325
[TBL] [Abstract][Full Text] [Related]
30. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
31. Interaction of nitric oxide and cGMP with signal transduction in activated platelets.
Nguyen BL; Saitoh M; Ware JA
Am J Physiol; 1991 Oct; 261(4 Pt 2):H1043-52. PubMed ID: 1656783
[TBL] [Abstract][Full Text] [Related]
32. Influence of the cGMP analog 8-PCPT-cGMP on agonist-induced increases in cytosolic ionized Ca2+ and on aggregation of human platelets.
Menshikov MYu ; Ivanova K; Schaefer M; Drummer C; Gerzer R
Eur J Pharmacol; 1993 May; 245(3):281-4. PubMed ID: 8392939
[TBL] [Abstract][Full Text] [Related]
33. Pyridoxine increases nitric oxide biosynthesis in human platelets.
Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
[TBL] [Abstract][Full Text] [Related]
34. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.
Ferreira MA; do Nascimento NR; de Sousa CM; Pessoa OD; de Lemos TL; Ventura JS; Schattner M; Chudzinski-Tavassi AM
Br J Pharmacol; 2008 Jul; 154(6):1216-24. PubMed ID: 18516074
[TBL] [Abstract][Full Text] [Related]
35. Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes.
Bergandi L; Cordero M; Anselmino M; Ferraro G; Ravera L; Dalmasso P; Moiraghi C; Trevi GP; Ghigo D; Bosia A; Bergerone S
Clin Res Cardiol; 2010 Sep; 99(9):557-64. PubMed ID: 20467748
[TBL] [Abstract][Full Text] [Related]
36. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.
Kleppe R; Jonassen I; Døskeland SO; Selheim F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462984
[TBL] [Abstract][Full Text] [Related]
37. High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets.
Russo I; Viretto M; Barale C; Mattiello L; Doronzo G; Pagliarino A; Cavalot F; Trovati M; Anfossi G
Diabetes; 2012 Nov; 61(11):2913-21. PubMed ID: 22837307
[TBL] [Abstract][Full Text] [Related]
38. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
39. Role of the NO-GC/cGMP signaling pathway in platelet biomechanics.
Balmes A; Rodríguez JG; Seifert J; Pinto-Quintero D; Khawaja AA; Boffito M; Frye M; Friebe A; Emerson M; Seta F; Feil R; Feil S; Schäffer TE
Platelets; 2024 Dec; 35(1):2313359. PubMed ID: 38353233
[TBL] [Abstract][Full Text] [Related]
40. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
